The therapy landscape for brain tumors, especially glioblastoma multiforme (GBM), the most severe type of brain cancer, has been completely transformed by temozolomide (TMZ). Since it was approved for usage in 1999, individuals with this terrible disease have seen far higher survival rates and improved quality of life. We may recognize temozolomide's vital part in contemporary oncology by...